Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
20.45
-0.86 (-4.04%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $339.08 million as of August 31, 2026. Its market cap has increased by 342.66% in one year.
Market Cap
339.08M
Enterprise Value
185.52M
1-Year Change
342.66%
Ranking
Category
Stock Price
$20.45
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $339.08M, a decrease of -2.26%. That is a compound annual growth rate of -0.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 339.08M | 244.01% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 356.31M |
| Lyell Immunopharma | 356.06M |
| Palisade Bio | 348.54M |
| Agenus | 344.86M |
| SAB Biotherapeutics | 344.84M |
| DiaMedica Therapeutics | 344.59M |
| Abeona Therapeutics | 338.53M |
| YD Bio | 337.54M |